Free Trial

Venture Visionary Partners LLC Raises Position in Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Venture Visionary Partners LLC lifted its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 4.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 104,355 shares of the company's stock after purchasing an additional 4,109 shares during the period. Venture Visionary Partners LLC's holdings in Procter & Gamble were worth $17,784,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of PG. Cladis Investment Advisory LLC boosted its holdings in Procter & Gamble by 5.2% in the 4th quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock valued at $806,000 after purchasing an additional 236 shares during the period. FAS Wealth Partners Inc. boosted its holdings in Procter & Gamble by 2.0% in the 4th quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company's stock valued at $4,642,000 after purchasing an additional 549 shares during the period. Benjamin Edwards Inc. boosted its holdings in Procter & Gamble by 120.7% in the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock valued at $62,098,000 after purchasing an additional 199,258 shares during the period. Capital Investment Advisory Services LLC boosted its holdings in Procter & Gamble by 13.8% in the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock valued at $6,426,000 after purchasing an additional 4,562 shares during the period. Finally, World Investment Advisors raised its position in shares of Procter & Gamble by 6.0% during the 1st quarter. World Investment Advisors now owns 50,913 shares of the company's stock valued at $8,677,000 after buying an additional 2,886 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $155.68 on Tuesday. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The company's 50-day moving average is $157.05 and its 200 day moving average is $163.17. The stock has a market capitalization of $364.66 billion, a P/E ratio of 23.91, a P/E/G ratio of 4.07 and a beta of 0.37.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. During the same quarter in the previous year, the company earned $1.40 earnings per share. Procter & Gamble's quarterly revenue was up 1.7% on a year-over-year basis. On average, sell-side analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were paid a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's payout ratio is presently 64.98%.

Wall Street Analysts Forecast Growth

PG has been the topic of several research reports. Wells Fargo & Company lowered their price objective on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Raymond James Financial lowered their price objective on shares of Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating on the stock in a research report on Friday, April 25th. Morgan Stanley set a $180.00 price objective on shares of Procter & Gamble and gave the company an "overweight" rating in a research report on Friday, April 25th. Bank of America lowered their price objective on shares of Procter & Gamble from $190.00 to $180.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Finally, JPMorgan Chase & Co. restated a "neutral" rating and set a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Seven equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $175.94.

Check Out Our Latest Research Report on PG

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines